Immunocore and Argenx Among Fast-Track Hopefuls At EMA
Five Accelerated Assessment Decisions Due, Including On Tebentafusp And Efgartigimod
• By Maureen Kenny
Getting A New Product To Market Faster Can Give Companies A Competitive Advantage • Source: Alamy 
